As a follow-up to our May 18, 2021 article, the bipartisan piece of legislation that unanimously passed the Texas House and Senate aimed at regulating pharmacy benefit managers (PBMs) was signed into law by Governor Greg Abbott. This is a huge win... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | DIR Fees | Life Sciences | Pharmacy Law

A bipartisan piece of legislation aimed at regulating pharmacy benefit managers (PBMs) in the State of Texas unanimously passed the House and Senate in Texas. Specifically, House Bill (HB) 1763 previously passed the Texas House by a vote of 147-0... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | DIR Fees | Life Sciences | Payor Network Access and Defense of Network Terminations | Pharmacy Law

On April 12, 2021, Senator Kolkhorst, along with a bipartisan group of cosponsors, introduced SB 2195, a Bill that prohibits Pharmacy Benefit Managers (“PBMs”) operating in Texas from assessing against pharmacies a variety of different types of... Read More
Blogs & Articles | Community, Retail Pharmacies | DIR Fees | Life Sciences | Payor Network Access and Defense of Network Terminations | Pharmacy Law

In Wisconsin, Governor Tony Evers recently signed a bipartisan bill into law aimed at regulating pharmacy benefit managers (PBMs). This law, which was unanimously passed in the Wisconsin legislature, is significant for several reasons including... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | DIR Fees | Life Sciences | Pharmacy Law

The specialty pharmacy space has proven to be a rewarding investment for private equity, as specialty medications typically lead the pharmacy trend cost curve, which will only continue as more than 60 new specialty medications expected to receive... Read More
Blogs & Articles | COVID-19 Resources | DIR Fees | Life Sciences | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies | Specialty Pharmacies

Has your pharmacy or dispensing practice recently received a remittance that included large “submission fees,” sometimes designated with the code “AH:444,” without explanation?  Frier Levitt has learned those fees are DIR fees being charged... Read More
Blogs & Articles | Community, Retail Pharmacies | DIR Fees | Life Sciences | Pharmacy Law